Girolamo Ranieri
Overview
Explore the profile of Girolamo Ranieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tommasi S, Maurmo L, Rizzo A, Carella C, Ranieri G, De Summa S, et al.
Front Med (Lausanne)
. 2024 Nov;
11:1511339.
PMID: 39526241
[This corrects the article DOI: 10.3389/fmed.2024.1432628.].
2.
Tommasi S, Maurmo L, Rizzo A, Carella C, Ranieri G, De Summa S, et al.
Front Med (Lausanne)
. 2024 Sep;
11:1432628.
PMID: 39323465
Introduction: The management of cancer patients follows a Diagnostic Therapeutic and Care Pathway (PDTA) approach, aimed at achieving the optimal balance between care and quality of life. To support this...
3.
Ammendola M, Vescio F, Rotondo C, Arturi F, Luposella M, Zuccala V, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124701
Adipose tissue macrophages (ATMs) and mast cells (MCs) play a role in immune responses. More recently, their involvement in tumor angiogenesis and chronic inflammatory conditions in patients with obesity has...
4.
Maqoud F, Zizzo N, Attimonelli M, Tinelli A, Passantino G, Antonacci M, et al.
Front Pharmacol
. 2023 May;
14:1115543.
PMID: 37180726
ATP-sensitive-K+ channels (KATP) are involved in diseases, but their role in cancer is poorly described. Pituitary macroadenoma has been observed in Cantu' syndrome (C.S.), which is associated with the gain-of-function...
5.
Laface C, Ranieri G, Maselli F, Ambrogio F, Foti C, Ammendola M, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765612
One of the most important abilities of a tumor is to establish a state of immunosuppression inside the tumor microenvironment. This is made possible through numerous mechanisms of tumor immune...
6.
Minici R, Siciliano M, Ammendola M, Santoro R, Barbieri V, Ranieri G, et al.
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612251
TACE plays a pivotal role in hepatocellular carcinoma, from disease control to downstaging and bridging to liver transplant. Response to TACE is a surrogate marker of tumor aggressive biology, with...
7.
Ambrogio F, Laface C, Sbarra G, Filotico R, Ranieri G, Barlusconi C, et al.
Vaccines (Basel)
. 2022 Nov;
10(11).
PMID: 36423067
The advent of vaccines has drastically reduced the incidence, morbidity, and mortality related to COVID-19, and with the increase in the number of vaccinated subjects, there have been reports of...
8.
Ammerata G, Filippo R, Laface C, Memeo R, Solaini L, Cavaliere D, et al.
World J Clin Cases
. 2022 Nov;
10(30):10852-10861.
PMID: 36338235
The pursuit of this paper is to collect principal reviews and systematic reviews about hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) used in colorectal cancer (CRC). We focus on...
9.
Laface C, Fedele P, Maselli F, Ambrogio F, Foti C, Molinari P, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36011021
Hepatocellular carcinoma (HCC) is the most frequent primitive cancer of the liver, accounting for 90% of all recorded cases. HCC is the third most common cause of cancer-related death, with...
10.
Ambrogio F, Laface C, Perosa F, Lospalluti L, Ranieri G, De Prezzo S, et al.
Intern Emerg Med
. 2022 Jul;
17(8):2339-2341.
PMID: 35781779
No abstract available.